Adecco Group AG (ETR:ADI1)

Revance Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	270	482	556	782	3,051	1,485
Trading Asset Securities	-	-	-	-	1	5
Cash & Short-Term Investments	270	482	556	782	3,052	1,490
Cash Growth	-19.64%	-13.31%	-28.90%	-74.38%	104.83%	10.29%
Accounts Receivable	4,281	4,118	4,466	4,758	4,076	3,870
Other Receivables	3	1	1	1	2	2
Receivables	4,284	4,119	4,467	4,759	4,078	3,872
Restricted Cash	70	71	49	86	61	42
Other Current Assets	494	408	416	497	532	350
Total Current Assets	5,118	5,080	5,488	6,124	7,723	5,754
Property, Plant & Equipment	925	704	749	717	465	533
Long-Term Investments	243	242	197	185	175	133
Goodwill	4,008	4,196	4,114	4,181	2,483	2,339
Other Intangible Assets	812	1,130	1,214	1,289	402	412
Long-Term Deferred Tax Assets	-	260	218	262	201	175
Other Long-Term Assets	743	487	450	498	416	446
Total Assets	11,849	12,099	12,430	13,256	11,865	9,792
Accounts Payable	4,269	757	832	1,162	879	766
Accrued Expenses	-	3,380	3,446	3,594	3,229	3,094
Short-Term Debt	482	53	87	134	49	45
Current Portion of Long-Term Debt	1	240	433	3	300	249
Current Portion of Leases	201	197	205	178	152	178
Current Income Taxes Payable	-	90	61	46	58	52
Other Current Liabilities	4	61	54	81	59	78
Total Current Liabilities	4,957	4,778	5,118	5,198	4,726	4,462
Long-Term Debt	2,740	2,747	2,684	3,161	2,786	1,590
Long-Term Leases	299	322	344	310	229	251
Long-Term Deferred Tax Liabilities	-	203	209	283	36	48
Other Long-Term Liabilities	648	364	378	303	183	118
Total Liabilities	8,644	8,513	8,829	9,363	8,065	6,574
Common Stock	11	11	11	11	11	10
Additional Paid-In Capital	542	552	557	669	814	582
Retained Earnings	3,211	3,269	3,398	3,412	3,361	3,139
Treasury Stock	-15	-36	-39	-58	-159	-89
Comprehensive Income & Other	-553	-220	-332	-153	-237	-433
Total Common Equity	3,196	3,576	3,595	3,881	3,790	3,209
Minority Interest	9	10	6	12	10	9
Shareholders' Equity	3,205	3,586	3,601	3,893	3,800	3,218
Total Liabilities & Equity	11,849	12,099	12,430	13,256	11,865	9,792
Total Debt	3,723	3,559	3,753	3,786	3,516	2,313
Net Cash (Debt)	-3,453	-3,077	-3,197	-3,004	-464	-823
Net Cash Per Share	-20.53	-18.28	-19.03	-17.98	-2.85	-5.08
Filing Date Shares Outstanding	168	167.44	167.56	167.12	165.08	161.14
Total Common Shares Outstanding	168	167.44	167.56	167.12	165.08	161.14
Working Capital	161	302	370	926	2,997	1,292
Book Value Per Share	19.02	21.36	21.46	23.22	22.96	19.91
Tangible Book Value	-1,624	-1,750	-1,733	-1,589	905	458
Tangible Book Value Per Share	-9.67	-10.45	-10.34	-9.51	5.48	2.84
Land	-	54	101	172	3	3
Machinery	-	258	266	259	223	268
Leasehold Improvements	-	255	249	205	198	205

Source: S&P Global Market Intelligence. Standard template. Financial Sources.